Skip to main content
Log in

Clinical vertebral fractures following denosumab discontinuation

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. A.D. Anastasilakis, P. Makras, Multiple clinical vertebral fractures following denosumab discontinuation. Osteoporos. Int. 27, 1929–1930 (2016)

    Article  CAS  PubMed  Google Scholar 

  2. B. Aubry-Rozier, E. Gonzalez-Rodriguez, D. Stoll, O. Lamy, Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports. Osteoporos. Int. 27, 1923–1925 (2016)

    Article  CAS  PubMed  Google Scholar 

  3. A.W. Popp, P.K. Zysset, K. Lippuner, Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics. Osteoporos. Int. 27, 1917–1921 (2016)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stergios A. Polyzos.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Polyzos, S.A., Terpos, E. Clinical vertebral fractures following denosumab discontinuation. Endocrine 54, 271–272 (2016). https://doi.org/10.1007/s12020-016-1030-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1030-6

Keywords

Navigation